![Debra Zack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Debra Zack
Technik-/Wissenschafts-/F&E-Leiter bei
SPERO THERAPEUTICS, INC.
Vermögen: 196 396 $ am 30.09.2026
Profil
Debra Jeske Zack is currently Chief Medical Officer at Spero Therapeutics, Inc. since 2026.
Former positions include Chief Medical Officer at Exagen, Inc. from 2020 to 2022, Executive Director-Global Product Area at Amgen, Inc., Vice President-Clinical Development at Xencor, Inc., and Associate Professor at the University of California, Los Angeles.
Education includes undergraduate studies at Texas Christian University and a doctorate from The University of Texas Southwestern Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC. 0,28 % | 03.08.2026 | 162 311 ( 0,28 % ) | 196 396 $ | 30.09.2026 |
Aktive Positionen von Debra Zack
| Unternehmen | Position | Beginn |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.07.2026 |
Ehemalige bekannte Positionen von Debra Zack
| Unternehmen | Position | Ende |
|---|---|---|
| EXAGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.12.2022 |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| XENCOR, INC. | Corporate Officer/Principal | - |
Ausbildung von Debra Zack
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
 Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exagen, Inc.
 Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
